Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $34.89 in the prior trading day, Harmony Biosciences Holdings Inc (NASDAQ: HRMY) closed at $34.56, down -0.95%. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 0.67 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HRMY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.95. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $55.
On December 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 24 ’25 when Dierks Jeffrey sold 13,125 shares for $37.31 per share. The transaction valued at 489,634 led to the insider holds 0 shares of the business.
Dierks Jeffrey sold 1,629 shares of HRMY for $61,941 on Jan 27 ’25. The CHIEF COMMERCIAL OFFICER now owns 0 shares after completing the transaction at $38.02 per share. On Jan 27 ’25, another insider, Kapadia Sandip, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 1,775 shares for $38.05 each. As a result, the insider received 67,547 and left with 0 shares of the company.
Valuation Measures:
As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.36, and their Forward P/E ratio for the next fiscal year is 10.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.89 while its Price-to-Book (P/B) ratio in mrq is 3.30.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $41.61, while it has fallen to a 52-week low of $28.14. The 50-Day Moving Average of the stock is -4.54%, while the 200-Day Moving Average is calculated to be 0.79%.
Shares Statistics:
A total of 57.03M shares are outstanding, with a floating share count of 43.16M. Insiders hold about 24.33% of the company’s shares, while institutions hold 83.60% stake in the company.
